TNPH OTC
Tian'an Pharmaceutical Co., Ltd.
1W: +0.0%
1M: +188.9%
3M: +188.9%
YTD: +687.9%
1Y: +983.3%
3Y: -33.3%
5Y: -25.9%
$0.03
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
$0
-100.0% ▼
Operating Income
-$18K
-72.9% ▼
Net Income
-$1K
+91.2% ▲
EPS (Diluted)
$0.00
+0.0% ▲
EBITDA
-$1K
+86.1% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $8K | $143K | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +1804.5% | -100.0% |
| Cost of Revenue | $0 | $0 | $0 | $75K | $0 |
| Gross Profit | $0 | $0 | $8K | $68K | $0 |
| Gross Margin | — | — | 100.0% | 47.3% | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $80K | $31K | $41K | $78K | $18K |
| Operating Expenses | $80K | $31K | $41K | $78K | $18K |
| Operating Income | -$80K | -$31K | -$33K | -$11K | -$18K |
| Operating Margin | — | — | -446.0% | -7.5% | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$80K | -$31K | -$20K | -$10K | -$1K |
| Tax Expense | $0 | $0 | $0 | $630 | $0 |
| Net Income | -$80K | -$31K | -$20K | -$16K | -$1K |
| Net Margin | — | — | -272.7% | -11.2% | — |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.00 | $0.00 | $0.00 |
| EBITDA | -$80K | -$31K | $208K | -$10K | -$1K |
| Shares Outstanding | 50M | 50M | 66M | 348M | 800M |